Nexus AI CXR is a CE MDR Class IIb certified chest X-ray AI solution designed to support accurate, efficient, and scalable lung health screening.
Nexus Intelligence (Pty) Ltd is a medical AI technology company focused on developing clinically validated, regulatory-approved AI solutions for lung health imaging.
We specialise in scalable AI solutions supporting population screening, public health programmes, occupational health, and enterprise radiology workflows worldwide – improving detection, workflow efficiency, and patient outcomes while making high-quality AI technology more affordable and sustainable.
Published in The Lancet. Powered by Google. Trusted by clients.
Every milestone – from the Google partnership to CE certification – was earned through rigorous clinical validation, independent peer review, and regulatory compliance.
Nexus AI CXR is engineered, validated, and deployed in full compliance with the international standards that matter most in medical AI.
Class IIb certified Software as a Medical Device. Approved for deployment in institutional healthcare environments and national screening programmes.
EN ISO 13485 certified Quality Management System for the design and manufacture of medical devices.
Medical device software lifecycle processes – full SOUP justification and traceability matrix maintained.
Application of risk management to medical devices. Risk-benefit analysis maintained throughout the product lifecycle.
Nexus works in active collaboration with the world's leading institutions on AI foundation models, clinical validation, procurement, and integrated ecosystem delivery.
Developed in collaboration with Google under a long-term Master Licence and Development Agreement covering the underlying machine learning models. Nexus retains full design, development, and regulatory responsibility for the commercial product.
Nexus AI is integrated within the Healthcare Framework clinical management platform and CloudX teleradiology service – together forming the Comprehensive Lung Health Ecosystem deployed across 20+ countries.
Independent external validation against 12 CAD AI vendors, external validation of the Silicosis model (Beta), and participation in TB REACH POCs in Cameroon and Vietnam.
Active deployments across multiple countries and Ministries of Health, the South African private mining sector for occupational lung health screening, TB REACH donation programmes, and the Nexus × Google in-kind social impact drive.
Quality-assessed and approved for procurement across Global Fund programmes. WHO PQ evaluation in progress – extending procurement readiness across global public health programmes.
Available for procurement through the Pooled Procurement Mechanism – extending market access across public health programmes.
Whether you're a ministry of health, a procurement partner, or a research institution – we'd like to hear from you.